Clinical trial
Evaluation of Efficacy and Safety of Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus
NCT02726867 is registered in ClinicalTrials.gov with Mid-Atlantic Epilepsy and Sleep Center, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Efficacy and Safety of Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus
- Lead sponsor
- Mid-Atlantic Epilepsy and Sleep Center, LLC
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- February 28, 2014
- Completion date
- November 30, 2016
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.